Retinopathy of prematurity (ROP) is a leading cause of preventable blindness in infants and children worldwide. India is experiencing an ROP epidemic, significantly impacting rural districts
L V Prasad Eye Institute and CognitiveCare has announced a partnership to jointly pursue efforts that advance the early detection of eye diseases and adverse eye conditions in infants and children. This partnership combines L V Prasad Eye Institute’s expertise and research in eye health with CognitiveCare’s AI platform, which incorporates granular insights and patterns that interplay with clinical and social determinants to quantify propensity for health risks at individual and population levels early.
Retinopathy of prematurity (ROP) is a leading cause of preventable blindness in infants and children worldwide. India is experiencing an ROP epidemic, significantly impacting rural districts. Furthermore, it is projected that the myopia epidemic will affect 50 per cent of the global population by 2050.
The prevalence of myopia in children in India has quadrupled in the past twenty years. Active prevention and mitigation strategies are needed to control and potentially reverse both the ROP and myopia trends currently seen in India.
Dr Prashant Garg, Executive Chair, L V Prasad Eye Institute said, “We are happy to partner with CognitiveCare and are confident that our combined expertise in clinical management and machine learning will help us accelerate the early diagnosis of ROP and Myopia in young children and infants. We are also hopeful that this partnership will pave way to leverage AI, deep learning, and advanced computational sciences to address several other critical eye diseases.”